IQVIA™ Market Prognosis 2018-2022

IQVIA and CPhI are pleased to bring you our special Market Prognosis report sharing our view of the future of the South Korean pharma market. Both CPhI and IQVIA consider that such information is key for the growth and development of the pharma industry and believe that this report will provide valuable insight as you look to develop your business in South Korea.

The report provides an evidence-based outlook for South Korea based on the knowledge of our country experts who carry out extensive research into key business and healthcare events and apply this to a gold standard historical view of the market.